Pembrolizumab-Induced Nasal Polyposis: The First Reported Case.

Justin M Hintze1,2, Holly Jones1,2, Peter Lacy1,2

  • 1Department of Otolaryngology, Beaumont Hospital, Dublin, Ireland.

Summary

Pembrolizumab, an immune checkpoint inhibitor, can cause chronic rhinosinusitis with nasal polyposis. This case study details a patient successfully treated with surgery, highlighting a rare side effect of cancer immunotherapy.